These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7646909)

  • 1. Nuclear DNA content of persistent tumour lacks prognostic relevance for length of survival in patients undergoing second-look laparotomy for ovarian cancer.
    Zanetta G; Keeney G; Katzmann J; Podratz KC
    Eur J Cancer; 1995 Jun; 31A(6):1027-8. PubMed ID: 7646909
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic significance of DNA content in epithelial ovarian cancer.
    Gajewski WH; Fuller AF; Pastel-Ley C; Flotte TJ; Bell DA
    Gynecol Oncol; 1994 Apr; 53(1):5-12. PubMed ID: 8175021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular DNA content--a stable feature in epithelial ovarian cancer.
    Friedlander ML; Taylor IW; Russell P; Tattersall MH
    Br J Cancer; 1984 Feb; 49(2):173-9. PubMed ID: 6696818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic significance of nuclear DNA content in malignant epithelial tumors of the ovary.
    Brescia RJ; Barakat RA; Beller U; Frederickson G; Suhrland MJ; Dubin N; Demopoulos RI
    Cancer; 1990 Jan; 65(1):141-7. PubMed ID: 2293860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic value of image analysis in ovarian cancer.
    Miller BE; Lavia LA; Horbelt DV
    Cancer; 1991 Mar; 67(5):1318-21. PubMed ID: 1991294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concordance of DNA ploidy pattern as measured by flow cytometry in primary, metastatic, and persistent ovarian carcinoma.
    Zanetta GM; Keeney GL; Kimlinger TK; Katzmann JA; Podratz KC
    Gynecol Oncol; 1996 Feb; 60(2):213-6. PubMed ID: 8631540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric analysis of nuclear DNA content in patients with recurrent epithelial ovarian cancer.
    Hamaguchi K; Nishimura H; Tateno N; Yakushiji M; Yokoyama MM
    Nihon Gan Chiryo Gakkai Shi; 1990 Dec; 25(12):2836-42. PubMed ID: 2074393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of flow cytometric DNA content analysis in granulosa cell tumor of the ovary.
    Klemi PJ; Joensuu H; Salmi T
    Cancer; 1990 Mar; 65(5):1189-93. PubMed ID: 2302667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The place of second-look laparoscopy in monitoring treatment of advanced malignant ovarian neoplasms].
    Skret A; Kluza R; Fabisiak W
    Ginekol Pol; 1997 Apr; 68(4):193-8. PubMed ID: 9463084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA flow cytometry as a new prognostic factor in ovarian malignancies. A review.
    Tropé C; Makar A; Kaern J
    Acta Obstet Gynecol Scand Suppl; 1992; 155():95-7. PubMed ID: 1502897
    [No Abstract]   [Full Text] [Related]  

  • 11. Surgical cytoreduction during second-look laparotomy in patients with advanced ovarian cancer.
    Gadducci A; Iacconi P; Fanucchi A; Cosio S; Teti G; Genazzani AR
    Anticancer Res; 2000; 20(3B):1959-64. PubMed ID: 10928134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of cell DNA content in early-stage ovarian cancer (FIGO stages I and II/A) by means of automatic image cytometry.
    Wagner TM; Adler A; Sevelda P; Assmann I; Knepflé CF; Czerwenka K; Heinzl H; Ploem-Zaaijer JJ
    Int J Cancer; 1994 Jan; 56(2):167-72. PubMed ID: 8314296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multivariate analysis of DNA ploidy, steroid hormone receptors, and CA 125 as prognostic factors in ovarian carcinoma: a prospective study.
    Eissa S; Khalifa A; Laban M; Mohamed MK; Elian A
    Nutrition; 1995; 11(5 Suppl):622-6. PubMed ID: 8748237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.
    Kimmig R; Wimberger P; Hillemanns P; Kapsner T; Caspari C; Hepp H
    Gynecol Oncol; 2002 Jan; 84(1):21-31. PubMed ID: 11748971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of nuclear DNA quantification and cyclin A expression in epithelial ovarian carcinoma.
    Yoon BS; Kim YT; Kim S; Lee CS; Kim JW; Kim JH; Kim SW; Cho NH
    Eur J Obstet Gynecol Reprod Biol; 2008 Jan; 136(1):110-5. PubMed ID: 17157431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [DNA content of ovarian tumors: correlation to established prognostic parameters and clinical course].
    Kristen P; Kaesemann H; Dostert M; Caffier H
    Gynakol Geburtshilfliche Rundsch; 1993; 33 Suppl 1():204-5. PubMed ID: 8118271
    [No Abstract]   [Full Text] [Related]  

  • 17. Influence of cellular DNA content on survival in advanced ovarian cancer.
    Friedlander ML; Hedley DW; Taylor IW; Russell P; Coates AS; Tattersall MH
    Cancer Res; 1984 Jan; 44(1):397-400. PubMed ID: 6690054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors for outcome of and survival after second-look laparotomy in patients with advanced ovarian carcinoma.
    Lund B; Williamson P
    Obstet Gynecol; 1990 Oct; 76(4):617-22. PubMed ID: 2216190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laparoscopic second look operation for ovarian cancer: single center experiences.
    Hong DG; Park NY; Chong GO; Cho YL; Park IS; Lee YS
    Minim Invasive Ther Allied Technol; 2011 Dec; 20(6):346-51. PubMed ID: 21413836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second-look laparotomy after modified posterior exenteration: patterns of persistence and recurrence in patients with stage III and stage IV ovarian cancer.
    Spirtos NM; Eisenkop SM; Schlaerth JB; Ballon SC
    Am J Obstet Gynecol; 2000 Jun; 182(6):1321-7. PubMed ID: 10871445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.